Circulating inflamma-miRs in aging and age-related diseases

Frontiers in Genetics

Volumn 4, Issue JUN, 2013, Pages

  Olivieri, Fabiola ^a,b   Rippo, Maria R ^a   Procopio, Antonio D ^a,b   Fazioli, Francesca ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b INRCA   (Italy)

Author keywords

Age related diseases; Cellular senescence; Circulating miRs; Inflammation mediators; NF B signaling

Indexed keywords

EID: 84883496441     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2013.00121     Document Type: Review

References (107)

1. Abou-Zeid, A., Saad, M., and Soliman, E. (2011). MicroRNA 146a expression in rheumatoid arthritis: association with tumor necrosis factor-alpha and disease activity. Genet. Test Mol. Biomarkers 15, 807-812. doi: 10.1089/gtmb.2011.0026
2. Alexandrov, P. N., Dua, P., Hill, J. M., Bhattacharjee, S., Zhao, Y., and Lukiw, W. J. (2012). MicroRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int. J. Biochem. Mol. Biol. 3, 365-373.
3. Asgeirsdóttir, S. A., van Solingen, C., Kurniati, N. F., Zwiers, P. J., Heeringa, P., van Meurs, M., et al. (2012). MicroRNA-126 contributes to renal microvascular heterogeneity of VCAM-1 protein expression in acute inflammation. Am. J. Physiol. Renal Physiol. 302, F1630-F1639. doi: 10.1152/ajprenal.00400.2011
4. Bala, S., Petrasek, J., Mundkur, S., Catalano, D., Levin, I., Ward, J., et al. (2012). Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 56, 1946-1957. doi: 10.1002/hep.25873
5. Balasubramanyam, M., Aravind, S., Gokulakrishnan, K., Prabu, P., Sathishkumar, C., Ranjani, H., et al. (2011). Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes. Mol. Cell. Biochem. 351, 197-205. doi: 10.1007/s11010-011-0727-3
6. Bazzoni, F., Rossato, M., Fabbri, M., Gaudiosi, D., Mirolo, M., Mori, L., et al. (2009). Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc. Natl. Acad. Sci. U.S.A. 106, 5282-5287. doi: 10.1073/pnas.0810909106
7. Blüml, S., Bonelli, M., Niederreiter, B., Puchner, A., Mayr, G., Hayer, S., et al. (2011). Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice. Arthritis Rheum. 63, 1281-1288. doi: 10.1002/art.30281
8. Boldin, M. P., and Baltimore, D. (2012). MicroRNAs, new effectors and regulators of NF-kB. Immunol. Rev. 246, 205-220. doi: 10.1111/j.1600-065X.2011.01089.x
9. Brase, J. C., Johannes, M., Schlomm, T., Falth, M., Haese, A., Steuber, T., et al. (2011). Circulating miRNAs are correlated with tumor progression in prostate cancer. Int. J. Cancer 128, 608-616. doi: 10.1002/ijc.25376
10. Breving, K., and Esquela-Kerscher, A. (2010). The complexities of microRNA regulation: mirandering around the rules. Int. J. Biochem. Cell Biol. 42, 1316-1329. doi: 10.1016/j.biocel.2009.09.016
11. Buscaglia, L. E., and Li, Y. (2011). Apoptosis and the target genes of microRNA-21. Chin. J. Cancer 30, 371-380.
12. Campisi, J., Andersen, J. K., Kapahi, P., and Melov, S. (2011). Cellular senescence: a link between cancer and age-related degenerative disease? Semin. Cancer Biol. 21, 354-359. doi: 10.1016/j.semcancer.2011.09.001
13. Carlsen, A. L., Schetter, A. J., Nielsen, C. T., Lood, C., Knudsen, S., and Voss, A. (2013). Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum. 65, 1324-1334. doi: 10.1002/art.37890
14. Ceppi, M., Pereira, P. M., Dunand-Sauthier, I., Barras, E., Reith, W., Santos, M. A., et al. (2009). MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 104, 2735-2740. doi: 10.1073/pnas.0811073106
15. Chen, X. M., Splinter, P. L., O'Hara, S. P., and LaRusso, N. F. (2007). A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J. Biol. Chem. 282, 28929-28938. doi: 10.1074/jbc.M702633200
16. Chen, Y., Chen, J., Wang, H., Shi, J., Wu, K., Liu, S., et al. (2013). HCV-induced miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1. PLoS Pathog. 9:e1003248. doi: 10.1371/journal.ppat.1003248
17. Chassin, C., Hempel, C., Stockinger, S., Dupont, A., Kübler, J. F., Wedemeyer, J., et al. (2012). MicroRNA-146a-mediated downregulation of IRAK1 protects mouse and human small intestine against ischemia/reperfusion injury. EMBO Mol. Med. 4, 1308-1319. doi: 10.1002/emmm.201201298
18. Collino, F., Deregibus, M. C., Bruno, S., Sterpone, L., Aghemo, G., Viltono, L., et al. (2010). Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS ONE 5:e11803. doi: 10.1371/journal.pone.0011803
19. Crone, S. G., Jacobsen, A., Federspiel, B., Bardram, L., Krogh, A., Lund, A. H., et al. (2012). microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer. Mol. Cancer 11, 71.
20. Cui, J. G., Li, Y. Y., Zhao, Y., Bhattacharjee, S., and Lukiw, W. J. (2010). Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease. J. Biol. Chem. 285, 38951-38960. doi: 10.1074/jbc.M110.178848
21. Czyzyk-Krzeska, M. F., and Zhang, X. (2013). MiR-155 at the heart of oncogenic pathways. Oncogene. doi: 10.1038/onc.2013.26. [Epub ahead of print].
22. Dai, L., Gu, L., and Di, W. (2012). MiR-199a attenuates endometrial stromal cell invasiveness through suppression of the IKKβ/NF-κB pathway and reduced interleukin-8 expression. Mol. Hum. Reprod. 18, 136-145. doi: 10.1093/molehr/gar066
23. Davalos, A. R., Coppe, J. P., Campisi, J., and Desprez, P. Y. (2010). Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis Rev. 29, 273-283. doi: 10.1007/s10555-010-9220-9
24. Ding, J., Huang, S., Wang, Y., Tian, Q., Zha, R., Shi, H., et al. (2013). Genome-wide screening revealed that miR-195 targets the TNF-α/NF-κB pathway by downregulating IKKα and TAB3 in hepatocellular carcinoma. Hepatology. doi: 10.1002/hep.26378. [Epub ahead of print].
25. Dunne, A., and O'Neill, L. (2005). Adaptor usage and Toll-like receptor signalling specificity. FEBS Lett. 579, 3330-3335. doi: 10.1016/j.febslet.2005.04.024
26. ElSharawy, A., Keller, A., Flachsbart, F., Wendschlag, A., Jacobs, G., Kefer, N., et al. (2012). Genome-wide miRNA signatures of human longevity. Aging Cell 11, 607-616. doi: 10.1111/j.1474-9726.2012.00824.x
27. Fabbri, M. (2012). TLRs as miRNA Receptors. Cancer Res. doi: 10.1158/0008-5472.CAN-12-3229. [Epub ahead of print].
28. Fabbri, M., Paone, A., Calore, F., Galli, R., Gaudio, E., Santhanam, R., et al. (2012). MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc. Natl. Acad. Sci. U.S.A. 109, E2110-E2116. doi: 10.1073/pnas.1209414109
29. Feng, X., Wang, H., Ye, S., Guan, J., Tan, W., Cheng, S., et al. (2012). Up-regulation of microRNA-126 may contribute to pathogenesis of ulcerative colitis via regulating NF-kappaB inhibitor IκBα. PLoS ONE 7:e52782. doi: 10.1371/journal.pone.0052782
30. Franceschi, C., Bonafè, M., Valensin, S., Olivieri, F., De Luca, M., Ottaviani, E., et al. (2000). Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N.Y. Acad. Sci. 908, 244-254. doi: 10.1111/j.1749-6632.2000.tb06651.x
31. Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., et al. (2013). TREM2 variants in Alzheimer's disease. N. Engl. J. Med. 368, 117-127. doi: 10.1056/NEJMoa1211851
32. Gombar, S., Jung, H. J., Dong, F., Calder, B., Atzmon, G., Barzilai, N., et al. (2012). Comprehensive microRNA profiling in B-cells of human centenarians by massively parallel sequencing. BMC Genomics 13:353. doi: 10.1186/1471-2164-13-353.
33. Harris, T. A., Yamakuchi, M., Ferlito, M., Mendell, J. T., and Lowenstein, C. J. (2008). MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl. Acad. Sci. U.S.A. 105, 1516-1521. doi: 10.1073/pnas.0707493105
34. Holohan, K. N., Lahiri, D. K., Schneider, B. P., Foroud, T., and Saykin, A. J. (2012). Functional microRNAs in Alzheimer's disease and cancer: differential regulation of common mechanisms and pathway. Front. Genet. 3:323. doi: 10.3389/fgene.2012.00323
35. Hosoda, T., Zheng, H., Cabral-da-Silva, M., Sanada, F., Ide-Iwata, N., Ogórek, B., et al. (2011). Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation 123, 1287-1296. doi: 10.1161/CIRCULATIONAHA.110.982918
36. Hou, Z., Yin, H., Chen, C., Dai, X., Li, X., Liu, B., et al. (2012). microRNA-146a targets the L1 cell adhesion molecule and suppresses the metastatic potential of gastric cancer. Mol. Med. Rep. 6, 501-506. doi: 10.3892/mmr.2012.946
37. Hurst, D. R., Edmonds, M. D., Scott, G. K., Benz, C. C., Vaidya, K. S., and Welch, D. R. (2009). Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res. 69, 1279-1283. doi: 10.1158/0008-5472.CAN-08-3559
38. Hwang, S. J., Seol, H. J., Park, Y. M., Kim, K. H., Gorospe, M., Nam, D. H., et al. (2012). MicroRNA-146a suppresses metastatic activity in brain metastasis. Mol. Cells 34, 329-334. doi: 10.1007/s10059-012-0171-6
39. Inukai, S., and Slack, F. (2013). MicroRNAs and the genetic network in aging. J. Mol. Biol. pii: S0022-2836(13)00039-9. doi: 10.1016/j.jmb.2013.01.023.
40. Iyer, A., Zurolo, E., Prabowo, A., Fluiter, K., Spliet, W. G., van Rijen, P. C., et al. (2012). MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS ONE 7:e44789. doi: 10.1371/journal.pone.0044789
41. Jakob, P., and Landmesser, U. (2012). Role of microRNAs in stem/progenitor cells and cardiovascular repair. Cardiovasc. Res. 93, 614-622. doi: 10.1093/cvr/cvr311
42. Jiang, M., Xiang, Y., Wang, D., Gao, J., Liu, D., Liu, Y., et al. (2012). Dysregulated expression of miR-146a contributes to age-related dysfunction of macrophages. Aging Cell 11, 29-40. doi: 10.1111/j.1474-9726.2011.00757.x
43. Jiang, T., Yu, J. T., Zhu, X. C., and Tan, L. (2013). TREM2 in Alzheimer's disease. Mol. Neurobiol. doi: 10.1007/s12035-013-8424-8. [Epub ahead of print].
44. Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., et al. (2013). Variant of TREM2 associated with the risk of Alzheimer's disease. N. Engl. J. Med. 368, 107-116. doi: 10.1056/NEJMoa1211103
45. Kawai, T., and Akira, S. (2011). Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637-650. doi: 10.1016/j.immuni.2011.05.006
46. Kim, S. W., Ramasamy, K., Bouamar, H., Lin, A. P., Jiang, D., and Aguiar, R. C. (2012). MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20). Proc. Natl. Acad. Sci. U.S.A. 109, 7865-7870. doi: 10.1073/pnas.1200081109
47. Kondo, T., Kawai, T., and Akira, S. (2012). Dissecting negative regulation of Toll-like receptor signaling. Trends Immunol. 33, 449-458. doi: 10.1016/j.it.2012.05.002
48. Kumar, M., Ahmad, T., Sharma, A., Mabalirajan, U., Kulshreshtha, A., Agrawal, A., et al. (2011). Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation. J. Allergy Clin. Immunol. 128, 1077-1085.e1-e10. doi: 10.1016/j.jaci.2011.04.034
49. Kumarswamy, R., Volkmann, I., and Thum, T. (2011). Regulation and function of miRNA-21 in health and disease. RNA Biol. 8, 706-713. doi: 10.4161/rna.8.5.16154
50. Kurowska-Stolarska, M., Alivernini, S., Ballantine, L. E., Asquith, D. L., Millar, N. L., Gilchrist, D. S., et al. (2011). MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc. Natl. Acad. Sci. U.S.A. 108, 11193-11198. doi: 10.1073/pnas.1019536108
51. Labbaye, C., and Testa, U. (2012). The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer. J. Hematol. Oncol. 5, 13. doi: 10.1186/1756-8722-5-13
52. Li, Y., Vandenboom, T. G. 2nd, Wang, Z., Kong, D., Ali, S., Philip, P. A., et al. (2010). miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res. 70, 1486-1495. doi: 10.1158/0008-5472.CAN-09-2792
53. Liang, D., Gao, Y., Lin, X., He, Z., Zhao, Q., Deng, Q., et al. (2011). A human herpesvirus miRNA attenuates interferon signalling and contributes to mainteinanceof viral latency by targeting IKK epsilon. Cell Res. 21, 793-806. doi: 10.1038/cr.2011.5
54. Liu, J., Mao, Q., Liu, Y., Hao, X., Zhang, S., and Zhang, J. (2013). Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. Chin. J. Cancer Res. 25, 46-54. doi: 10.3978/j.issn.1000-9604.2012.11.04
55. Liu, Z., Lu, C. L., Cui, L. P., Hu, Y. L., Yu, Q., Jiang, Y., et al. (2012). MicroRNA-146a modulates TGF-β1-induced phenotypic differentiation in human dermal fibroblasts by targeting SMAD4. Arch. Dermatol. Res. 304, 195-202. doi: 10.1007/s00403-011-1178-0
56. Lukiw, W. J., Zhao, Y., and Cui, J. G. (2008). An NF-κB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J. Biol. Chem. 283, 31315-31322. doi: 10.1074/jbc.M805371200
57. Lukiw, W. J. (2012). NF-κB-regulated, proinflammatory miRNAs in Alzheimer's disease. Alzheimers Res. Ther. 4, 47. doi: 10.1186/alzrt150
58. Lukiw, W. J., and Alexandrov, P. N. (2012). Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain. Mol. Neurobiol. 46, 11-19. doi: 10.1007/s12035-012-8234-4
59. Lukiw, W. J., Andreeva, T. V., Grigorenko, A. P., and Rogaev, E. I. (2012a). Studying micro RNA function and dysfunction in Alzheimer's disease. Front. Genet. 3:327. doi: 10.3389/fgene.2012.00327
60. Lukiw, W. J., Alexandrov, P. N., Zhao, Y., Hill, J. M., and Bhattacharjee, S. (2012b). Spreading of Alzheimer's disease inflammatory signaling through soluble micro-RNA. Neuroreport 23, 621-626. doi: 10.1097/WNR.0b013e32835542b0
61. Mar-Aguilar, F., Mendoza-Ramírez, J. A., Malagón-Santiago, I., Espino-Silva, P. K., Santuario-Facio, S. K., Ruiz-Flores, P., et al. (2013). Serum circulating microRNA profiling for identification of potential breast cancer biomarkers. Dis. Markers 34, 163-169. doi: 10.3233/DMA-120957
62. Matsumoto, S., Sakata, Y., Nakatani, D., Suna, S., Mizuno, H., Shimizu, M., et al. (2012). A subset of circulating microRNAs are predictive for cardiac death after discharge for acute myocardial infarction. Biochem. Biophys. Res. Commun. 427, 280-284. doi: 10.1016/j.bbrc.2012.09.039
63. Mrak, R. E., and Griffin, W. S. (2001). Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol. Aging 22, 903-908. doi: 10.1016/S0197-4580(01)00287-1
64. Murray, P. J., and Smale, S. T. (2012). Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways. Nat. Immunol. 13, 916-924. doi: 10.1038/ni.2391
65. Nazari-Jahantigh, M., Wei, Y., Noels, H., Akhtar, S., Zhou, Z., Koenen, R. R., et al. (2012). MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J. Clin. Invest. 122, 4190-4202. doi: 10.1172/JCI61716
66. Nilsen, T. W. (2007). Mechanisms of microRNA-mediated gene regulation in animal cells. Trends Genet. 23, 243-249. doi: 10.1016/j.tig.2007.02.011
67. O'Connell, R. M., Chaudhuri, A. A., Rao, D. S., and Baltimore, D. (2009). Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. U.S.A. 106, 7113-7118. doi: 10.1073/pnas.0902636106
68. Olarerin-George, A. O., Anton, L., Hwang, Y. C., Elovitz, M. A., and Hogenesch, J. B. (2013). A functional genomics screen for microRNA regulators of NF-kappaB signaling. BMC Biol. 11:19. doi: 10.1186/1741-7007-11-19
69. Olivieri, F., Rippo, M. R., Prattichizzo, F., Babini, L., Graciotti, L., Recchioni, R., et al. (2013a). Toll like receptor signaling in "inflammaging": microRNA as new players. Immun. Ageing 10, 11. doi: 10.1186/1742-4933-10-11
70. Olivieri, F., Recchioni, R., Marcheselli, F., Abbatecola, A. M., Santini, G., Borghetti, G., et al. (2013b). Cellular senescence in cardiovascular diseases: potential age-related mechanisms and implications for treatment. Curr. Pharm. Des. 19, 1710-1719.
71. Olivieri, F., Antonicelli, R., Recchioni, R., Mariotti, S., Marcheselli, F., Lisa, R., et al. (2013c). Telomere/telomerase system impairment in circulating angiogenic cells of geriatric patients with heart failure. Int. J. Cardiol. 164, 99-105. doi: 10.1016/j.ijcard.2011.06.091
72. Olivieri, F., Spazzafumo, L., Santini, G., Lazzarini, R., Albertini, M. C., Rippo, M. R., et al. (2012a). Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging. Mech. Ageing Dev. 133, 675-685. doi: 10.1016/j.mad.2012.09.004
73. Olivieri, F., Lazzarini, R., Recchioni, R., Marcheselli, F., Rippo, M. R., Di Nuzzo, S., et al. (2012b). MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling. Age (Dordr.). doi: 10.1007/s11357-012-9440-8. [Epub ahead of print].
74. Olivieri, F., Antonicelli, R., Lorenzi, M., D'Alessandra, Y., Lazzarini, R., Santini, G., et al. (2012c). Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int. J. Cardiol. doi: 10.1016/j.ijcard.2012.01.075. [Epub ahead of print].
75. Orjalo, A. V., Bhaumik, D., Gengler, B. K., Scott, G. K., and Campisi, J. (2009). Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc. Natl. Acad. Sci. U.S.A. 106, 17031-17036. doi: 10.1073/pnas.0905299106
76. Pigati, L., Yaddanapudi, S. C., Iyengar, R., Kim, D. J., Hearn, S. A., Danforth, D., et al. (2010). Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS ONE 5:e13515. doi: 10.1371/journal.pone.0013515
77. Pritchard, C. C., Kroh, E., Wood, B., Arroyo, J. D., Dougherty, K. J., Miyaji, M. M., et al. (2012). Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev. Res. (Phila.) 5, 492-497. doi: 10.1158/1940-6207.CAPR-11-0370
78. Quinn, S., and O'Neill, L. A. (2011). A trio of microRNAs that control toll-like receptor signalling. Int. Immunol. 23, 421-425. doi: 10.1093/intimm/dxr034
79. Reid, G., Kirschner, M. B., and van Zandwijk, N. (2011). Circulating microRNAs: association with disease and potential use as biomarkers. Crit. Rev. Oncol. Hematol. 80, 193-208. doi: 10.1016/j.critrevonc.2010.11.004
80. Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., et al. (2007). Requirement of bic/microRNA-155 for normal immune function. Science 316, 608-611. doi: 10.1126/science.1139253
81. Roggli, E., Britan, A., Gattesco, S., Lin-Marq, N., Abderrahmani, A., Meda, P., et al. (2010). Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. Diabetes 59, 978-986. doi: 10.2337/db09-0881
82. Schulte, L. N., Westermann, A. J., and Vogel, J. (2013). Differential activation and functional specialization of miR-146 and miR-155 in innate immune sensing. Nucleic Acids Res. 41, 542-553. doi: 10.1093/nar/gks1030
83. Serna, E., Gambini, J., Borras, C., Mohammed, K., Belenguer, A., Sanchis, P., et al. (2012). Centenarians, but not octogenarians, up-regulate the expression of microRNAs. Sci. Rep. 2, 961. doi: 10.1038/srep00961
84. Sheddy, F. J., Palsson-McDermott, E., Hennessy, E. J., Martin, C., O'Leary, J. J., Ruan, Q., et al. (2010). Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat. Immunol. 11, 141-147. doi: 10.1038/ni.1828
85. Spazzafumo, L., Olivieri, F., Abbatecola, A. M., Castellani, G., Monti, D., Lisa, R., et al. (2013). Remodelling of biological parameters during human ageing: evidence for complex regulation in longevity and in type 2 diabetes. Age (Dordr.) 35, 419-429. doi: 10.1007/s11357-011-9348-8
86. Squadrito, M. L., Etzrodt, M., De Palma, M., and Pittet, M. J. (2013). MicroRNA-mediated control of macrophages and its implications for cancer. Trends Immunol. pii: S1471-4906(13)00029-X. doi: 10.1016/j.it.2013.02.003
87. Sredni, S. T., Gadd, S., Jafari, N., and Huang, C. C. (2011). A parallel study of mRNA and microRNA profiling of peripheral blood in young adult women. Front. Genet. 2:49. doi: 10.3389/fgene.2011.00049
88. Sun, Y., Cai, J., Ma, F., Lü, P., Huang, H., and Zhou, J. (2012). miR-155 mediates suppressive effect of progesterone on TLR3, TLR4-triggered immune response. Immunol. Lett. 146, 25-30. doi: 10.1016/j.imlet.2012.04.007
89. Taganov, K. D., Boldin, M. P., Chang, K. J., and Baltimore, D. (2006). NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signalling proteins of innate immune responses. Proc. Natl. Acad. Sci. U.S.A. 103, 12481-12486. doi: 10.1073/pnas.0605298103
90. Tomasetti, M., Staffolani, S., Nocchi, L., Neuzil, J., Strafella, E., Manzella, N., et al. (2012). Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients. Clin. Biochem. 45, 575-581. doi: 10.1016/j.clinbiochem.2012.02.009
91. Turchinovich, A., Weiz, L., Langheinz, A., and Burwinkel, B. (2011). Characterization of extracellular circulating microRNA. Nucleic Acids Res. 39, 7223-7233. doi: 10.1093/nar/gkr254
92. Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., and Lötvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659. doi: 10.1038/ncb1596
93. Wahlgren, J., De L Karlson, T., Brisslert, M., Vaziri Sani, F., Telemo, E., Sunnerhagen, P., et al. (2012). Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res. 40, e130. doi: 10.1093/nar/gks463
94. Wang, K., Zhang, S., Weber, J., Baxter, D., and Galas, D. J. (2010). Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 38, 7248-7259. doi: 10.1093/nar/gkq601
95. Wang, L. L., Huang, Y., Wang, G., and Chen, S. D. (2012). The potential role of microRNA-146 in Alzheimer's disease: biomarker or therapeutic target. Med. Hypotheses 78, 398-401. doi: 10.1016/j.mehy.2011.11.019
96. Waters, P. S., McDermott, A. M., Wall, D., Heneghan, H. M., Miller, N., and Newell, J. (2012). Relationship between circulating and tissue microRNAs in a murine model of breast cancer. PLoS ONE 7:e50459. doi: 10.1371/journal.pone.0050459
97. Wei, Y., Nazari-Jahantigh, M., Neth, P., Weber, C., and Schober, A. (2013). MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 33, 449-454. doi: 10.1161/ATVBAHA.112.300279
98. Williams, A. E., Perry, M. M., Moschos, S. A., Larner-Svensson, H. M., and Lindsay, M. A. (2008). Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem. Soc. Trans. 36, 1211-1125. doi: 10.1042/BST0361211
99. Xie, Q., Wang, S. C., Zhong, J., and Li, J. (2013). MicroRNA-146a, a good biomarker, and potential therapeutic target for rheumatoid arthritis. Genet. Test Mol. Biomarkers 17, 91-92. doi: 10.1089/gtmb.2012.0333
100. Xu, C., Ren, G., Cao, G., Chen, Q., Shou, P., Zheng, C., et al. (2013). MiR-155 Regulates Immune modulatory properties of mesenchymal stem cells by targeting TAK1-binding protein 2. J. Biol. Chem. 288, 11074-11079. doi: 10.1074/jbc.M112.414862
101. Yao, R., Ma, Y., Du, Y., Liao, M., Li, H., Liang, W., et al. (2011). The altered expression of inflammation-related microRNAs with microRNA-155 expression correlates with Th17 differentiation in patients with acute coronary syndrome. Cell. Mol. Immunol. 8, 486-495. doi: 10.1038/cmi.2011.22
102. Yao, Q., Cao, S., Li, C., Mengesha, A., Kong, B., and Wei, M. (2011). Micro-RNA-21 regulates TGF-β-induced myofibroblast differentiation by targeting PDCD4 in tumor-stroma interaction. Int. J. Cancer 128, 1783-1792. doi: 10.1002/ijc.25506
103. Zampetaki, A., Kiechl, S., Drozdov, I., Willeit, P., Mayr, U., Prokopi, M., et al. (2010). Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ. Res. 107, 810-817. doi: 10.1161/CIRCRESAHA.110.226357
104. Zhang, X., Azhar, G., and Wei, J. Y. (2012). The expression of microRNA and microRNA clusters in the aging heart. PLoS ONE 7:e34688. doi: 10.1371/journal.pone.0034688
105. Zhao, J. L., Rao, D. S., Boldin, M. P., Taganov, K. D., O'Connell, R. M., and Baltimore, D. (2011). NF-kappaB dysregulation in microRNA-146a deficient mice drives the development of myeloid malignancies. Proc. Natl. Acad. Sci. U.S.A. 108, 9184-9189. doi: 10.1073/pnas.1105398108
106. Zhou, J., Wang, K. C., Wu, W., Subramaniam, S., Shyy, J. Y., Chiu, J. J., et al. (2011). MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proc. Natl. Acad. Sci. U.S.A. 108, 10355-10360. doi: 10.1073/pnas.1107052108
107. Zhu, S., Deng, S., Ma, Q., Zhang, T., Jia, C., Zhuo, D., et al. (2013). MicroRNA-10A* and MicroRNA-21 modulate endothelial progenitor cell senescence via suppressing high-mobility group A2. Circ. Res. 112, 152-164. doi: 10.1161/CIRCRESAHA.112.280016